Within our Joint Care Intervention portfolio, we offer a targeted solution for deferring osteoarthritis with Hyalosyn™ Gel. The Hyaluronic Acid (HA) injections supplement the natural human HA found in the synovial joints, and increase the shock-absorbing capacity as well as reduce pain. Additionally, this portfolio offers a solution for osteotomy with our range of OssGro® synthetic grafts promoting bone regeneration.
Leader Biomedical’s Joint Care Reconstruction portfolio offers targeted solutions for replacement and revision and includes VarioNXT® and VarioClassic™ hip systems, as well as a range of PMMA bone cements, a cement restrictor, and single-use sterile accessories including a mixing set and wound irrigation system. Further, this portfolio offers eTiss® void fillers and Osteomycin™ for bone regeneration in revision surgeries.
Our Joint Care Stabilisation portfolio includes targeted solutions for replacement and guided bone regeneration in trauma indications with the VarioClassic™ hip system, a range of OssGro® synthetic grafts, Ossfinity®, and eTiss® allografts.
Note: not all products of the corporate therapeutic solutions portfolios may be available in all regions/countries. Please refer to your local sales contact for more information.